|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Erratum: Vol. 46, No. 8In (Table_2) of the report "National, State, and Urban Area Vaccination Coverage Levels Among Children Aged 19-35 Months -- United States, January-December 1995," the text of the ** and double dagger footnotes is incorrect. The corrected table appears on page 228. Table_2 Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size. TABLE 2. Estimated vaccination coverage with the 4:3:1 series * and the 4:3:1:3 series +, by coverage level and state -- United States, National Immunization Survey, 1995 =================================================================== 4:3:1 Series Coverage --------------------- Coverage level/State % (95% CI &) ------------------------------------------ >=85% Connecticut @ 85 (+/-4.7) Maine @ 89 (+/-3.8) New Hampshire @ 87 (+/-3.8) Vermont @ 86 (+/-4.1) 75%-84% Alabama @ 77 (+/-4.6) Colorado @ 78 (+/-5.3) Delaware ** 75 (+/-5.8) Florida ** 76 (+/-4.6) Georgia @ 78 (+/-4.8) Hawaii @ 81 (+/-5.5) Illinois @ 81 (+/-4.0) Indiana ** 76 (+/-4.6) Iowa ** 83 (+/-4.2) Kentucky ** 80 (+/-5.5) Louisiana ** 77 (+/-4.6) Maryland @ 81 (+/-4.3) Massachusetts @ 81 (+/-4.3) Minnesota ++ 77 (+/-5.3) Mississippi ++ 83 (+/-5.0) Missouri @ 76 (+/-5.6) Nebraska @ 78 (+/-5.0) New Jersey @ 75 (+/-5.3) New Mexico ** 77 (+/-5.5) New York @ 79 (+/-4.2) North Carolina @ 81 (+/-5.0) North Dakota @ 82 (+/-4.8) Oklahoma ** 76 (+/-5.6) Pennsylvania @ 78 (+/-4.5) Rhode Island @ 83 (+/-4.7) South Carolina @ 80 (+/-4.7) South Dakota && 80 (+/-4.5) Texas @ 76 (+/-3.5) Washington @ 78 (+/-4.2) Wisconsin @ 77 (+/-3.8) 65%-74% Alaska ** 74 (+/-6.3) Arizona ** 73 (+/-4.8) Arkansas @ 74 (+/-5.5) California ** 71 (+/-4.6) Idaho ** 66 (+/-5.9) Kansas && 72 (+/-5.8) Michigan ** 70 (+/-4.8) Montana ** 74 (+/-5.4) Nevada ** 68 (+/-6.3) Ohio ** 74 (+/-4.2) Oregon ** 74 (+/-5.7) Tennessee ** 74 (+/-4.0) Utah ** 68 (+/-5.3) Virginia ** 74 (+/-5.8) West Virginia ++ 73 (+/-5.6) Wyoming ++ 74 (+/-5.6) Total 76 (+/-1.0) 4:3:1:3 Series Coverage ----------------------- Coverage level/State % (95% CI) ------------------------------------------- >=85% Maine 87 (+/-3.9) New Hampshire 86 (+/-3.8) 75%-84% Alabama 75 (+/-4.7) Colorado 77 (+/-5.4) Connecticut 83 (+/-4.9) Florida 75 (+/-4.6) Georgia 77 (+/-4.9) Hawaii 78 (+/-5.8) Illinois 79 (+/-4.1) Indiana 75 (+/-4.6) Iowa 82 (+/-4.4) Kentucky 79 (+/-5.6) Louisiana 76 (+/-4.7) Maryland 78 (+/-4.5) Massachusetts 80 (+/-4.3) Minnesota 76 (+/-5.4) Mississippi 81 (+/-5.2) Missouri 75 (+/-5.7) Nebraska 75 (+/-5.2) New Mexico 76 (+/-5.6) New York 77 (+/-4.3) North Carolina 80 (+/-5.0) North Dakota 81 (+/-4.8) Pennsylvania 76 (+/-4.7) Rhode Island 82 (+/-4.8) South Carolina 80 (+/-4.7) South Dakota 79 (+/-4.5) Vermont 84 (+/-4.3) Washington 77 (+/-4.2) 65%-74% Alaska 72 (+/-6.4) Arizona 70 (+/-4.9) Arkansas 73 (+/-5.6) California 69 (+/-4.6) Delaware 72 (+/-5.9) Kansas 70 (+/-5.8) Michigan 67 (+/-4.9) Montana 71 (+/-5.6) Nevada 65 (+/-6.3) New Jersey 72 (+/-5.5) Ohio 73 (+/-4.3) Oklahoma 73 (+/-5.7) Oregon 72 (+/-5.8) Tennessee 73 (+/-4.0) Texas 73 (+/-3.6) Utah 66 (+/-5.3) Virginia 71 (+/-5.9) West Virginia 71 (+/-5.6) Wisconsin 74 (+/-3.9) Wyoming 71 (+/-5.7) <65% Idaho 64 (+/-5.9) Total 74 (+/-1.0) ------------------------------------------------------------------- * Four or more doses of diphtheria and tetanus toxoids and pertussis vaccine/Diphtheria and tetanus toxoids (DTP/DT), three or more doses of poliovirus vaccine, and one or more doses of measles-containing vaccine (MCV). + Four or more doses of DTP/DT, three or more doses of poliovirus vaccine, one or more doses of MCV, and three or more doses of Haemophilus influenzae type b vaccine (Hib). & Confidence interval. @ Achieved the 1995 Childhood Immunization Initiative (CII) goals for three or more doses of DTP, three or more doses of poliovirus vaccine, one or more doses of MCV, three or more doses of Hib, and three or more doses of hepatitis B vaccine. ** Did not achieve the 1995 CII goal for at least one of the following: three or more doses of DTP, three or more doses of poliovirus vaccine, one or more doses of MCV, or three or more doses of Hib but achieved the 1995 goal for three or more doses of hepatitis B vaccine. ++ Achieved the 1995 CII goals for three or more doses of DTP, three or more doses of poliovirus vaccine, one or more doses of MCV, and three or more doses of Hib but not for three or more doses of hepatitis B vaccine. && Did not achieve the 1995 CII goal for at least one of the following: three or more doses of DTP, three or more doses of poliovirus vaccine, one or more doses of MCV, or three or more doses of Hib and did not achieve the 1995 goal for three or more doses of hepatitis B vaccine. =================================================================== Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|